• Home
  • About Us
  • List of Health Insurance Companies

Health Plan News

Timely Health Plan News and Commmentary.

Health Plan News
Home Healthcare Plan News Servatus raises $7.5 million to advance autoimmune therapies

Servatus raises $7.5 million to advance autoimmune therapies

Posted on December 8, 2021 Written by Annalyn Frame

Servatus Ltd is an unlisted Australian biopharmaceutical firm and global expert in the development and identification of new autoimmune therapies using live microbial biotherapeutics. It has received strong support from its sophisticated shareholders.

Servatus’ business includes three integrated divisions. Drug development is at the forefront in microbiome-based biotherapeutics. State-of-the art manufacturing via a joint venture. And Servatus also has a Biomiq over-the counter live microbial biotherapeutics company.

Most of the funds raised so far will go towards clinical trials for insomnia and rheumatoid arthritis (IBDUC). Servatus is currently awaiting final ethics clearance for rheumatoid and IBD-UC before attempting patient recruitment. These trials are expected to start in Queensland and the United States early in 2022.

The global rheumatoid-arthritis market is the largest, with USD43bn of drug sales in 2018. [1]. While the market for insomnia is large as well, and expected to grow at a CAGR 5.2% [2] in 2026, the market for insomnia is also very large. Pre-clinical studies have shown that Servatus’ drug candidate candidates either significantly improved the performance of certain of the most popular autoimmune drugs in the world or outperformed current standards of care.

Dr Wayne Finlayson (CEO of Servatus) commented on the success capital raise. He said that: “We are thrilled to have secured $7.5million in new capital to further these important clinical trials programs. Although there are medications available for rheumatoid and insomnia, significant numbers of patients are still not being treated or receiving the right treatment. We received exceptional feedback on our previous work and we look forward to opening the clinic in early 2019.

Servatus built a world-class research and production facility as part of a joint venture called Australian Biotherapeutics. This facility uses a world-first bio-manufacturing method that combines proprietary closed-system continuous production with Australian-first drying technology. It is designed to increase both manufacturing yields as well as production costs.

The first stage of construction has been completed. The joint venture will produce export-ready biopharmaceutical products, which will provide a significant revenue stream to the Servatus company. In 2023, stage two will be completed. This stage will include a larger production facility that allows large-scale GMP biopharmaceutical production.

Dr Wayne Finlayson is the CEO of Servatus. He said: “It was very satisfying to see how our integrated business platform has benefited this year. Our state-of the-art R&D facility and production facility have supported our rapidly expanding clinical trial program. Our purpose-built facility allows us to accelerate our clinical trial program, unlike other drug developers who may be affected by the shortage of manufacturing resources. We are proud to have been able to bring our Australian technology to the rest of the world, and we are now entering an exciting phase in the company’s history.

Filed Under: Healthcare Plan News

Recent News

  • Numinus completes acquisition of Novamind June 13, 2022
  • NRx Pharmaceuticals Provides Update on Breakthrough Therapy Designation (BTD) Request for ZYESAMI® (aviptadil) June 13, 2022
  • King Insurance Acquires Wurzel Insurance June 13, 2022
  • Medicare Advantage Plans Earn High Marks in eHealth Survey June 13, 2022
  • Curated Mental Health Partners with Brooklyn Minds Psychiatry April 20, 2022
  • HEALTHWORXS: A Game Changer, No Cost Healthcare Plan April 20, 2022
  • Study Finds Consumers Want Their Physician to Lead April 20, 2022
  • Peer-Reviewed Journal Spotlights Lirio’s Approach to Behavioral Design and Its Ability to Impact Underserved Communities April 20, 2022
  • Braxia Scientific Provides Update on Clinical Trials for Ketamine and Psilocybin Drug Development February 8, 2022
  • Numinus Identified as a Licensed Psilocybin Supplier January 31, 2022

About Annalyn Frame

I am a nursing student currently, but have been interested in healthcare since I was much younger. It’s as if I have always known that I would eventually end up being a nurse or going into the healthcare industry.

I am the editor of Health Plan News.

Search Our Site

Ketamine Therapy Dallas
Ketamine Treatment Clinic Dallas

Categories

  • AARP
  • Aetna
  • AMERIGROUP
  • Blue Cross Blue Shield
  • Canadian Health Care System
  • Canadian Pharmacies
  • Cardinal Health
  • Chubb
  • CIGNA HealthCare
  • COVID-19
  • diabetes
  • Enterologics
  • Facilities And Providers
  • FDA
  • GlaxoSmithKline
  • Health Clinics
  • Health Insurance Coverage
  • Health Plan Enrollment
  • Healthcare Companies
  • Healthcare Plan News
  • HealthSouth
  • Home Care
  • Home Health Care Insurance
  • Hospitals
  • Humana
  • J.P. Morgan Healthcare Conference
  • Lidocaine
  • LifeTree eClinical
  • Lipitor
  • Liposuction
  • MedBasics
  • Medicaid
  • Medical And Healthcare
  • Medical Devices
  • Medicare
  • Mevion Medical Systems
  • Mobile Healthcare
  • Pharmaceutical Companies
  • Senior News
  • The SCOOTER Store
  • Thoracic Surgeons
  • thrombocytopenia
  • Today Sponge
  • Top Health Care Networks
  • Total Lumbar Fusion Graft Spine Surgery
  • Toxic Air Pollution
  • Trans Fats
  • Travel Insurance
  • Triglycerides
  • Tuberculosis
  • Unilife
  • United Healthcare
  • UnitedHealth Group
  • Unused Medications
  • Uterine fibroids
  • Vaccines
  • varicella
  • Ventas
  • Vyteris
  • WakeUpWalmart
  • Wal-Mart Healthcare Crisis
  • Walgreens Pharmacy
  • Water Quality
  • WebMD
  • WellPoint
  • West Nile Virus
  • Wilmer Shields Rich Awards
  • World Health Care Congress
  • Wound Management
  • Zelnorm
  • Zocor
  • ZOLOFT

Pages

  • 1199 National Benefit Fund
  • A Little about Drug Preparation and Formulation Development
  • About Us
  • Affordable Health Insurance
  • Benefits of Hiring a Senior Caregiving Service
  • Catastrophic Health Insurance
  • Cheap Health Insurance
  • Cheap Health Insurance Plans
  • Child Health Insurance Plans
  • Choosing a Health Insurance Plan
  • Christian Health Insurance
  • Dental Assistants and Their Future
  • Dr. Howard Bellin: Questions about Rhinoplasty
  • Finding the Right Dentist
  • Get Your Winks in Blink
  • Health Insurance
  • Health Insurance Plans For Family
  • Health Sharing Plans
  • Healthcare and Hospitals: Disinfection is Key
  • High Deductible Health Plans
  • Home Care Employment in Arizona
  • How A Medical Weight Loss Plan Can Help You Get The Figure You Want
  • How Ketamine Therapy Helps Fight Depression
  • How Orthotic Insoles Improve Your Health
  • Individual Health Insurance Plans
  • Ketamine Uses and Benefits
  • List of Health Insurance Companies
  • Low Income Health Insurance
  • Medical Research Consultants
  • Personal Lubricants for Women – Liven Up Your Life!
  • Private Health Insurance Plans
  • Rhesus Negative
  • Self Employed Health Insurance
  • Short Term Health Insurance Plans
  • Student Health Insurance Plans
  • Temporary Health Insurance
  • The Basic Building Blocks For a Sustained, Healthy Diet
  • The Importance of Clinical Study Software
  • The Use of Post Cycle Therapy Supplements
  • Travel Health Insurance

Copyright © 2022 · Focus Pro Theme on Genesis Framework · WordPress · Log in

Go to mobile version